Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
about
mRNAs and miRNAs in whole blood associated with lung hyperplasia, fibrosis, and bronchiolo-alveolar adenoma and adenocarcinoma after multi-walled carbon nanotube inhalation exposure in miceAortic carboxypeptidase-like protein (ACLP) enhances lung myofibroblast differentiation through transforming growth factor β receptor-dependent and -independent pathwaysRecent advances in understanding idiopathic pulmonary fibrosisCardiac manifestations of idiopathic pulmonary fibrosisCandidate genes of idiopathic pulmonary fibrosis: current evidence and researchPharmacological Treatment of Idiopathic Pulmonary Fibrosis: Current Approaches, Unsolved Issues, and Future PerspectivesIdiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural historyState of the art in the diagnosis and management of interstitial lung diseasePirfenidone in idiopathic pulmonary fibrosis: expert panel discussion on the management of drug-related adverse eventsMolecular classification of idiopathic pulmonary fibrosis: personalized medicine, genetics and biomarkersPersonalized medicine: applying 'omics' to lung fibrosisThe psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature reviewIPF clinical trial design and endpointsIs there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?Interstitial lung disease: raising the index of suspicion in primary careRespiratory disease and respiratory physiology: putting lung function into perspective interstitial lung diseaseBleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" diseaseIdiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challengesExosomes and Exosomal miRNA in Respiratory DiseasesIdiopathic Pulmonary Fibrosis: Treatment and PrognosisReal World Experiences: Pirfenidone and Nintedanib are Effective and Well Tolerated Treatments for Idiopathic Pulmonary FibrosisUpdate on therapeutic management of idiopathic pulmonary fibrosisMatrix metalloproteinase-10: a novel biomarker for idiopathic pulmonary fibrosisPrognostic factors of idiopathic inflammatory myopathies complicated with interstitial lung disease: protocol for a systematic review and meta-analysisCurcumin modulates the inflammatory response and inhibits subsequent fibrosis in a mouse model of viral-induced acute respiratory distress syndromeClinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.FAK-related nonkinase is a multifunctional negative regulator of pulmonary fibrosis.Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis.Idiopathic pulmonary fibrosis in Saudi Arabia: Demographic, clinical, and survival data from two tertiary care hospitalsImpact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumoniaBaseline serum syndecan-4 predicts prognosis after the onset of acute exacerbation of idiopathic interstitial pneumoniaTelomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.Mechanical ventilation in idiopathic pulmonary fibrosis: a nationwide analysis of ventilator use, outcomes, and resource burden.Update in diffuse parenchymal lung disease 2011Idiopathic pulmonary fibrosis in East Asian.Role of the lysophospholipid mediators lysophosphatidic acid and sphingosine 1-phosphate in lung fibrosis.Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.Pathogenesis of idiopathic pulmonary fibrosis: review of recent findings.Idiopathic pulmonary fibrosis: new insights on functional characteristics at diagnosis.The value of CT for disease detection and prognosis determination in combined pulmonary fibrosis and emphysema (CPFE).
P2860
Q23910476-A5F715A0-7BF2-491E-AFED-CAC0D8D636F9Q24611248-030F5E04-21D5-4EAC-82B8-2AC369FD533DQ26745905-5EA0C782-AE3B-40BE-973A-288F89388379Q26748176-AB8622B5-0892-4CE9-B21E-A86BDE701717Q26764812-C51D81EF-5DE9-4B21-A004-384CA50BE60EQ26771309-C1A1160E-D313-45C0-9883-71C6EDD73AB6Q26776473-9334EF29-1892-4B8A-AAED-02AA3AAB388DQ26777295-5C95409B-077B-4CAA-9067-2005F83CC3B1Q26824810-4A69869C-B7E4-4029-A04F-E45096436DD5Q26864836-2E3468D6-75F1-417E-80FD-2A40188C8271Q26866919-3E8B4E36-6F82-4FB4-B4CF-6C5C0A64991EQ26992007-FDAB02FE-ED4F-4DCD-8B14-7A77C7067CEAQ26995648-A16365FB-A480-496F-9C2A-5B72305336AFQ26998459-7AFF6373-0652-418F-8B9F-6FFDA4FAA329Q27001028-F1D5490D-5B38-4F7A-BF5B-70D9129642F1Q27001599-09C56A9D-0895-4267-9F11-2C7253F9F870Q27333940-B3319644-5502-4494-87C9-737D598C8B67Q27499290-27071621-5087-4EA0-A6B7-BCDD7E75C1E9Q28066319-A57E4370-7259-475B-A937-839D400DDAB8Q28073641-D1F07586-941B-46E6-8A08-49A5EFFDD249Q28075536-4F84A79E-222D-41A9-BF71-77A66E498085Q28083944-D59BD7F3-1631-48C1-9D94-9634EED70722Q28389850-92B29B77-1F1C-43AE-B3F8-5563B7E2BF92Q28395250-21D21DDD-7509-4D5D-AA03-6369D19E6D18Q28486257-06E8BE9D-8BFD-4D91-AD09-1F218B406826Q30275807-B673F9F3-A30A-425A-96A8-3669B77C5054Q30413255-902BC374-489C-480B-AC2E-E3B0E12F5DC6Q30415751-3842D7A4-0E14-4919-BF9F-5165756BC288Q30834669-1189BDDD-0B15-434D-A56E-D8A0973EFF5DQ30846353-EA01C4B2-266A-4988-AD96-BF1871F61FE8Q33632632-1A7223BA-442C-4E08-BEA9-3213CAC2A1CCQ33692595-22145E4A-E4A2-4E36-8015-759F758FA801Q33717071-D15D0D99-142A-45B1-B1B2-28B21E52D8D6Q33738931-185FA52A-5D9D-4A16-83D8-6699210899C6Q33747908-117A8772-E7ED-4056-95C7-C0E854325148Q33756825-70A5CF23-4B90-4C6E-93BE-A76A81E9DD95Q33829662-7F722AFC-C5FA-45CD-B6C1-1BD5671960B3Q34019921-E8134876-A91B-4102-8EFB-10F610EDFA63Q34026607-C22A686D-0209-412E-A4FF-C9A0D6BF5396Q34156210-ED204207-E92E-4ABC-BE6E-8F4B78662AB3
P2860
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
@en
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
@nl
type
label
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
@en
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
@nl
prefLabel
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
@en
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
@nl
P2093
P2860
P1476
Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
@en
P2093
Harold R Collard
Talmadge E King
P2860
P304
P356
10.1164/RCCM.201006-0894CI
P407
P577
2010-10-08T00:00:00Z